14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ELWT vs LMRI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, ELWT (ELWT) is the stronger overall head-to-head candidate over LMRI (LMRI) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ELWT carries a Unified Composite Score of 51.7/100 (HOLD) at $2.97 (N/M Forward P/E, -55.0% operating margin), whereas LMRI carries 32.1/100 (SELL) at $14.26 (N/M Forward P/E, N/A operating margin).
Technical & Structure Timing Caution: ELWT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.3); meanwhile LMRI trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 62.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ELWT vs LMRI. Trailing 12-month operating profitability (ELWT -55.0% vs LMRI N/A) and valuation multiples (ELWT N/M vs LMRI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ELWT vs LMRI Key Questions & Quantitative Answers
As of Nov 20, 2026, ELWT (ELWT) is the stronger overall head-to-head candidate over LMRI (LMRI) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ELWT carries a Unified Composite Score of 51.7/100 (HOLD) at $2.97 (N/M Forward P/E, -55.0% operating margin), whereas LMRI carries 32.1/100 (SELL) at $14.26 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: ELWT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.3); meanwhile LMRI trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 62.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ELWT leads the Growth & Scale pillar: ELWT posts +6.6% YoY revenue growth and +0.0% YoY earnings growth on $19M TTM revenue (10.0% gross margin, -55.0% operating margin), compared with LMRI at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ELWT generates $19M in USD-normalized revenue versus N/A for LMRI. In operating R&D and SG&A reinvestment, ELWT deploys 65.0% of Rev ($12M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for LMRI.
ELWT screens cheaper on headline valuation multiples. ELWT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.1x EV/Revenue (unreported cash flow margin), whereas LMRI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ELWT (0.0% ROE) versus LMRI (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, ELWT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.20β · 88% Vol realized risk). By comparison, LMRI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.22β · 85% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.